Latest filing published 18 Jul 2022 for 泽璟制药.
Jisheng Wu(吴济生): trading record in brief
Jisheng Wu(吴济生) is a declared insider of 泽璟制药 (board member), with filings sourced from SSE / SZSE (CSRC). Between 11 March 2022 and 18 July 2022, the trades on record add up to 7 filings.
The open-market record is one-sided, with 7 purchases worth €145k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €9,718. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 18 July 2022, reports an open-market purchase of €8,794 in 泽璟制药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jisheng Wu(吴济生)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,784 sharesA股XSHGSSE:173000005692962100Canonical exit: 16 Oct 2022 (T+90)
- 1,050 sharesA股XSHGSSE:173000005649137920Canonical exit: 29 Sept 2022 (T+90)
- 2,000 sharesA股XSHGSSE:173000005547914300Canonical exit: 22 Aug 2022 (T+90)
- 2,000 sharesA股XSHGSSE:173000005367543580Canonical exit: 14 Jun 2022 (T+90)
- 11,000 sharesA股XSHGSSE:173000005365277760Canonical exit: 13 Jun 2022 (T+90)
- 7,000 sharesA股XSHGSSE:173000005361184800Canonical exit: 12 Jun 2022 (T+90)
- 4,000 sharesA股XSHGSSE:173000005358935000Canonical exit: 9 Jun 2022 (T+90)
7 of 7 declarations